9 Meters Biopharma, Inc. to Present at the Jefferies Virtual Healthcare Conference

Rhea-AI Summary

9 Meters Biopharma (NASDAQ:NMTR) announced that CEO John Temperato will present at the Jefferies Virtual Healthcare Conference from June 1-4, 2021. The presentation is scheduled for June 4, 2021, from 12:30 to 12:55 p.m. ET. Investors can participate via a webcast and arrange one-on-one meetings with management. The conference will feature over 400 healthcare companies and 3,000 executives, exploring investment opportunities and trends in healthcare. Following the session, a replay will be available for 30 days.

RALEIGH, NC / ACCESSWIRE / June 1, 2021 / 9 Meters Biopharma, Inc. (NASDAQ:NMTR), a clinical-stage company focused on rare and unmet needs in gastroenterology, today announced that John Temperato, CEO of 9 Meters Biopharma will present at the Jefferies Virtual Healthcare Conference being held June 1- 4, 2021 and invites investors to participate via webcast and in one-on-one meetings. The presentation will be followed by a virtual Q&A session.

Jefferies Virtual Healthcare Conference

Date: June 4th, 2021
Time: 12:30 to 12:55 p.m. (ET)
Presenter: John Temperato, CEO of 9 Meters Biopharma
Webcast: https://wsw.com/webcast/jeff174/nmtr/1878903

* a replay will be available following the presentation for 30 days

Please contact your Jefferies representative to schedule virtual one-on-one meetings with the
9 Meters Biopharma management team during the conference.

About Jefferies Virtual Healthcare Conference

The annual June conference will be held virtually with video presentations, keynotes, panels and 1x1/small group meetings via Zoom.

This virtual gathering of over 400 public & private healthcare companies and 3,000 leading executives, institutional investors, private equity investors & VCs will address near- and long-term investment opportunities and discuss the current trends driving healthcare in the U.S. and internationally.

For further information, please visit: www.Jefferies.com

About 9 Meters Biopharma
9 Meters Biopharma, Inc. ("the Company") is a rare and unmet needs-focused gastroenterology company. The Company is advancing vurolenatide, a proprietary long-acting GLP-1 agonist, into a Phase 2 trial for short bowel syndrome (SBS), a rare, orphan disease, as well as larazotide, a Phase 3 tight junction regulator being evaluated for symptom improvement in non-responsive celiac disease.

For more information, please visit www.9meters.com or follow 9 Meters on Twitter and LinkedIn.

Corporate Contacts:

Edward J. Sitar
Chief Financial Officer
9 Meters Biopharma, Inc.
investor-relations@9meters.com
www.9meters.com

Media Contact:

Veronica Eames
LifeSci Communications, LLC
veames@lifescicomms.com
203-942-4626

Investor Contact:

Corey Davis, Ph.D.
LifeSci Advisors, LLC
cdavis@lifesciadvisors.com
212-915-2577

SOURCE: 9 Meters Biopharma

View source version on accesswire.com:
https://www.accesswire.com/649585/9-Meters-Biopharma-Inc-to-Present-at-the-Jefferies-Virtual-Healthcare-Conference

FAQ

When will 9 Meters Biopharma present at the Jefferies Virtual Healthcare Conference?

9 Meters Biopharma will present on June 4, 2021, from 12:30 to 12:55 p.m. ET.

What is the web address for the Jefferies Virtual Healthcare Conference presentation by 9 Meters Biopharma?

The presentation can be accessed at this webcast link.

How long will the replay of the 9 Meters Biopharma presentation be available?

The replay of the presentation will be available for 30 days.

What type of company is 9 Meters Biopharma focusing on?

9 Meters Biopharma focuses on rare and unmet needs in gastroenterology.

How many companies are participating in the Jefferies Virtual Healthcare Conference?

The conference will feature over 400 public and private healthcare companies.